THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer

THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer

Abstract Background Long-term use of adjuvant endocrine therapy (AET) among women with early-stage, hormone receptor-positive breast cancer significantly reduces the risk of hospitalizations, cancer recurrence, and mortality. AET is associated with adverse symptoms that often result in poor adherenc...

Full description

Bibliographic Details
Main Authors: Andrew J. Paladino, Janeane N. Anderson, Rebecca A. Krukowski, Teresa Waters, Mehmet Kocak, Carolyn Graff, Ryan Blue, Tameka N. Jones, Joanne Buzaglo, Gregory Vidal, Lee Schwartzberg, Ilana Graetz
Format: Article
Language:English
Published: BMC 2019-12-01
Series:BMC Health Services Research
Subjects:
Randomized controlled trial
Adjuvant endocrine therapy
Breast cancer
Medication adherence
Mhealth
Patient-reported outcomes
Online Access:https://doi.org/10.1186/s12913-019-4588-x

Internet

https://doi.org/10.1186/s12913-019-4588-x

Similar Items